190P Ex vivo modeling of precision immuno-oncology responses in lung cancer

Naaa + dendritic cells (DCs), among others.TLS also enriched for certain clones in TCR/ BCR repertoires.Conclusions: Through photocatalytic covalent labeling with biotin, we achieved image-guided labeling of live TLS cells for scRNA-seq and identified TLS-enriched cells with potential functions in antigen presentation, cytotoxicity and antibody secretion.We anticipate detecting changes in TLS signatures and functions following PI3K drug treatment, enabling a comprehensive analysis of TLS.Moreover, we plan to refine our methodology to expand the scope of application in other crucial biomedical research areas.

Authors

Institutions

Publication Details

Journal
Immuno-Oncology Technology
Published
2024-12-01
DOI
https://doi.org/10.1016/j.iotech.2024.100943
Primary Topic
Monoclonal and Polyclonal Antibodies Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

190P Ex vivo modeling of precision immuno-oncology responses in lung cancer

Kimmo Peltonen, J. Klievink, Shadi Jansouz, Mikko Rönty et al.
Immuno-Oncology Technology
Monoclonal and Polyclonal Antibodies Research
article

190P Ex vivo modeling of precision immuno-oncology responses in lung cancer

Kimmo Peltonen, J. Klievink, Shadi Jansouz, Mikko Rönty, Jari Räsänen, Juhani Smolander, Eva Sutinen, Pipsa Saharinen, Laura Lahtinen, Mari Ainola, Ilkka Ilonen, Hanna Laitinen, S. Mustjoki, Elli Narvi, Heidi M. Haikala, Bassel Alsaed, Elina Jokinen, Li Li, Anil K. Thotakura, Nina Bobik
article en

Abstract

Naaa + dendritic cells (DCs), among others.TLS also enriched for certain clones in TCR/ BCR repertoires.Conclusions: Through photocatalytic covalent labeling with biotin, we achieved image-guided labeling of live TLS cells for scRNA-seq and identified TLS-enriched cells with potential functions in antigen presentation, cytotoxicity and antibody secretion.We anticipate detecting changes in TLS signatures and functions following PI3K drug treatment, enabling a comprehensive analysis of TLS.Moreover, we plan to refine our methodology to expand the scope of application in other crucial biomedical research areas.

Immuno-Oncology TechnologyVol. 24
University of Helsinki (FI), Helsinki University Hospital (FI), Orion Corporation (Finland) (FI)
Good health and well-being
Openalex Percentile: Top 60%
Monoclonal and Polyclonal Antibodies Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.